Increased IL-7 expression in Vogt-Koyanagi-Harada disease

Area of Science:

• Immunology
• Autoimmunity
• Ophthalmology

Background:

• Interleukin-7 (IL-7) and its receptor (IL-7R) are implicated in the pathogenesis of various autoimmune diseases.
• Vogt Koyanagi-Harada (VKH) disease is an organ-specific autoimmune disorder.

Purpose of the Study:

• To investigate the potential role of the IL-7/IL-7R axis in the pathogenesis of Vogt Koyanagi-Harada (VKH) disease.
• To assess IL-7 levels and IL-7R expression in VKH patients.

Main Methods:

• Serum IL-7 levels were quantified using ELISA in active VKH, inactive VKH, and healthy controls.
• IL-7R expression on CD4(+) T cells was analyzed via flow cytometry (FCM).
• Peripheral blood mononuclear cells (PBMCs) and CD4(+) T cells were stimulated with recombinant IL-7 to assess proliferation, cytokine production (IL-17, IFN-γ), and Th1/Th17 cell expansion using FCM and ELISA.

Main Results:

• Serum IL-7 levels were significantly elevated in active VKH patients compared to inactive VKH patients and healthy controls (P < 0.001).
• No significant difference in IL-7Rα expression on CD4(+) T cells was observed between VKH patients and controls.
• Recombinant IL-7 significantly induced PBMCs and CD4(+) T cell proliferation, IL-17 and IFN-γ secretion, and promoted the expansion of Th1 and Th17 cells.

Conclusions:

• The study findings indicate that IL-7 plays a significant role in the pathogenesis of Vogt Koyanagi-Harada disease.
• Elevated IL-7 levels in active VKH suggest it as a potential therapeutic target.